Your browser doesn't support javascript.
loading
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.
Shapiro, Roman M; Birch, Grace C; Hu, Guangan; Vergara Cadavid, Juliana; Nikiforow, Sarah; Baginska, Joanna; Ali, Alaa K; Tarannum, Mubin; Sheffer, Michal; Abdulhamid, Yasmin Z; Rambaldi, Benedetta; Arihara, Yohei; Reynolds, Carol; Halpern, Max S; Rodig, Scott J; Cullen, Nicole; Wolff, Jacquelyn O; Pfaff, Kathleen L; Lane, Andrew A; Lindsley, R Coleman; Cutler, Corey S; Antin, Joseph H; Ho, Vincent T; Koreth, John; Gooptu, Mahasweta; Kim, Haesook T; Malmberg, Karl-Johan; Wu, Catherine J; Chen, Jianzhu; Soiffer, Robert J; Ritz, Jerome; Romee, Rizwan.
Afiliação
  • Shapiro RM; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Birch GC; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Hu G; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
  • Vergara Cadavid J; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Nikiforow S; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Baginska J; Center for Immuno-oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Ali AK; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Tarannum M; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Sheffer M; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Abdulhamid YZ; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Rambaldi B; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Arihara Y; University of Milano-Bicocca, Monza, Italy.
  • Reynolds C; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Halpern MS; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Rodig SJ; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Cullen N; Department of Pathology and.
  • Wolff JO; Department of Pathology and.
  • Pfaff KL; Department of Pathology and.
  • Lane AA; Department of Pathology and.
  • Lindsley RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Cutler CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Antin JH; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Ho VT; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Koreth J; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Gooptu M; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Kim HT; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Malmberg KJ; Department of Data Science, Dana-Farber Cancer Institute/Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Wu CJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Chen J; Institute for Clinical Medicine, The University of Oslo, Oslo, Norway.
  • Soiffer RJ; Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Solna, Sweden.
  • Ritz J; Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Romee R; Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
J Clin Invest ; 132(11)2022 06 01.
Article em En | MEDLINE | ID: mdl-35349491
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-2 / Transplante de Células-Tronco Hematopoéticas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article